Viewing Study NCT03776058


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-04 @ 9:33 PM
Study NCT ID: NCT03776058
Status: COMPLETED
Last Update Posted: 2018-12-14
First Post: 2018-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2000-06-15
Start Date Type: ACTUAL
Primary Completion Date: 2000-12-26
Primary Completion Date Type: ACTUAL
Completion Date: 2000-12-26
Completion Date Type: ACTUAL
First Submit Date: 2018-12-13
First Submit QC Date: None
Study First Post Date: 2018-12-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-12-13
Last Update Post Date: 2018-12-14
Last Update Post Date Type: ACTUAL